J. Scott Laprise is a Canadian citizen born in 1962 who has worked in healthcare and medical equipment companies for over 30 years. He has held roles such as stock analyst, general manager, and marketing manager in China, Singapore, Canada, and the United States. Laprise has extensive experience analyzing the automotive, steel, and healthcare sectors in Asia and advising international clients. He is fluent in English, French, and Mandarin Chinese.
Lowe´s global sourcing productos para la remodelación de hogar (materiales ...ProColombia
The document summarizes the history and operations of LGS Sourcing, Inc. It discusses how LGS began sourcing products from Taiwan and Hong Kong in the late 1990s and early 2000s and has since expanded to India, Mexico, and China, becoming one of the largest importers in the US. It outlines LGS's global team across Asia and North America, their roles in merchandising, quality control, and supply chain management. Examples are given of successful merchandising stories and partnerships. The document promotes diversifying sourcing beyond China to countries like Mexico, India, and Southeast Asia and increasing support for merchants through expanded international teams.
Urs H. Flueckiger has over 30 years of experience in senior management roles in the pharmaceutical industry. He has a Masters in Economics and has worked for Roche in various countries, including Switzerland, South Korea, the Philippines, and Saudi Arabia. His experience includes launching new drugs, managing country operations, and closing/divesting facilities. Currently he is the Chairman of TwentyTwelve AG, a fashion retail business in Basel.
1) Brilliance Auto is a Chinese automaker that produces BMW vehicles through a joint venture. The JV contributes over 100% of Brilliance's profits, making it a proxy for BMW's China business.
2) BMW's model cycle is bottoming out, which will lead to lower prices and flat margins for BMW vehicles produced by the JV in the next two years.
3) Brilliance's self-branded vehicles remain unprofitable. The analyst expects the underperforming self-branded business to have little impact on profits going forward.
Daniel White has over 30 years of experience in medical device sales and marketing. He has held leadership roles at several companies introducing new medical technologies and building sales organizations. Most recently, he was Vice President of Sales and Marketing at Stellen Medical, where he helped launch a new tissue matrix product and restarted sales of burn care products.
Robert Heinrich is a results-oriented marketing and sales executive with over 30 years of experience in the medical device industry. He has held leadership roles at several companies, including Vice President roles at AnthonyProducts, Signus Medical, and Pioneer Surgical Technology. He has a proven track record of transforming organizations and successfully launching new products. Prior to that, he worked at Smith & Nephew for 14 years in various director roles in marketing and business development.
Scott Johnson has over 15 years of experience in pharmaceutical sales, consistently exceeding sales goals and ranking highly within his company. He was promoted to focus on specialty care areas and launched new products that significantly increased market share and trials. Johnson also has a background in marketing copywriting and business services sales, winning awards for new accounts and sales volume. He holds a Bachelor's degree in Communications Studies and English from BYU.
David Vosicher has over 10 years of experience in medical device and biotech sales. He has held several roles of increasing responsibility at companies like OrthAlign, Smith & Nephew, Rochester Medical, and Akorn. In his most recent role at OrthAlign, he managed a large territory and finished in the top 3 for sales, growing revenue by 30%. He has a track record of success launching new products, territories, and business lines.
Robert Ody has over 20 years of experience in sales and sales management in the medical device industry. He has a proven track record of achieving significant sales growth and successfully launching new products. His experience includes positions as Director of Sales, Vice President of Sales, and Regional Sales Manager for several companies.
Lowe´s global sourcing productos para la remodelación de hogar (materiales ...ProColombia
The document summarizes the history and operations of LGS Sourcing, Inc. It discusses how LGS began sourcing products from Taiwan and Hong Kong in the late 1990s and early 2000s and has since expanded to India, Mexico, and China, becoming one of the largest importers in the US. It outlines LGS's global team across Asia and North America, their roles in merchandising, quality control, and supply chain management. Examples are given of successful merchandising stories and partnerships. The document promotes diversifying sourcing beyond China to countries like Mexico, India, and Southeast Asia and increasing support for merchants through expanded international teams.
Urs H. Flueckiger has over 30 years of experience in senior management roles in the pharmaceutical industry. He has a Masters in Economics and has worked for Roche in various countries, including Switzerland, South Korea, the Philippines, and Saudi Arabia. His experience includes launching new drugs, managing country operations, and closing/divesting facilities. Currently he is the Chairman of TwentyTwelve AG, a fashion retail business in Basel.
1) Brilliance Auto is a Chinese automaker that produces BMW vehicles through a joint venture. The JV contributes over 100% of Brilliance's profits, making it a proxy for BMW's China business.
2) BMW's model cycle is bottoming out, which will lead to lower prices and flat margins for BMW vehicles produced by the JV in the next two years.
3) Brilliance's self-branded vehicles remain unprofitable. The analyst expects the underperforming self-branded business to have little impact on profits going forward.
Daniel White has over 30 years of experience in medical device sales and marketing. He has held leadership roles at several companies introducing new medical technologies and building sales organizations. Most recently, he was Vice President of Sales and Marketing at Stellen Medical, where he helped launch a new tissue matrix product and restarted sales of burn care products.
Robert Heinrich is a results-oriented marketing and sales executive with over 30 years of experience in the medical device industry. He has held leadership roles at several companies, including Vice President roles at AnthonyProducts, Signus Medical, and Pioneer Surgical Technology. He has a proven track record of transforming organizations and successfully launching new products. Prior to that, he worked at Smith & Nephew for 14 years in various director roles in marketing and business development.
Scott Johnson has over 15 years of experience in pharmaceutical sales, consistently exceeding sales goals and ranking highly within his company. He was promoted to focus on specialty care areas and launched new products that significantly increased market share and trials. Johnson also has a background in marketing copywriting and business services sales, winning awards for new accounts and sales volume. He holds a Bachelor's degree in Communications Studies and English from BYU.
David Vosicher has over 10 years of experience in medical device and biotech sales. He has held several roles of increasing responsibility at companies like OrthAlign, Smith & Nephew, Rochester Medical, and Akorn. In his most recent role at OrthAlign, he managed a large territory and finished in the top 3 for sales, growing revenue by 30%. He has a track record of success launching new products, territories, and business lines.
Robert Ody has over 20 years of experience in sales and sales management in the medical device industry. He has a proven track record of achieving significant sales growth and successfully launching new products. His experience includes positions as Director of Sales, Vice President of Sales, and Regional Sales Manager for several companies.
Rudi Jansen is a business executive with over 25 years of experience in the pharmaceutical industry. He has held CEO positions in Europe and has extensive experience turning around businesses. He is seeking new executive positions and enjoys developing businesses, fundraising, and working with teams.
Steven M. Green is an award-winning sales executive with success introducing medical products across Europe and the US. He established a $40 million market for Angiox in Europe in only 2 years and is ranked in the top 10 sales executives in the US. Green has expertise growing sales through international strategies, leading teams, and engaging with decision makers. Recent successes include growing Recothrom sales by over 8% to $2.2 million and increasing Cleviprex sales 250% to $5.6 million with a team of four.
Dwayne Poteet has over 35 years of experience in sales and business development, primarily in the medical device industry. He has a proven track record of exceeding sales goals and establishing distribution networks in over 70 countries. Most recently, as Director of Global Government Solutions at Welch Allyn, he secured over $1.1 million in contracts for medical monitors with the Department of Homeland Security and equipment for immigration detention centers. Poteet has held leadership roles at several medical device companies, growing international sales from six figures to $22 million.
The document discusses strategic alliances and joint ventures between pharmaceutical companies. It provides details of four examples of partnerships: Merck partnered with Alnylam in a non-equity strategic alliance to collaborate on RNAi drug development. GSK partnered with Dong-A through an equity strategic alliance to co-promote products in South Korea. Hisun and Pfizer formed a joint venture to collaborate on local production and distribution in China. Intrexon partnered with Sun Pharmaceuticals through a joint venture to develop new methods for treating ocular diseases using synthetic biology.
Chris Conner has over 18 years of experience in pharmaceutical sales, specializing in oncology and infectious diseases. He has held several executive sales specialist roles promoting products for conditions like chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom's macroglobulinemia, ulcerative colitis, and hepatitis C. Conner has a track record of success launching new products and growing market share. He has received numerous awards for sales performance and leadership. Currently, Conner works as a senior executive oncology specialist for Janssen Biotech, promoting their treatment for hematologic malignancies.
CJR Advisors provides strategic marketing and commercial assessment consulting services. Charlie Raffin is the president and has over 30 years of experience in various roles within Johnson & Johnson, including vice president positions assessing new products and developing global marketing strategies. He has extensive leadership experience in the pharmaceutical and diagnostic industries.
CJR Advisors provides strategic marketing and commercial assessment consulting services. Charlie Raffin is the president and has over 30 years of experience in various roles within Johnson & Johnson, including vice president positions assessing new products and developing global marketing strategies. He has extensive leadership experience in the pharmaceutical and diagnostic industries.
This document contains a summary of an individual's contact information, objective, professional experience, and key strengths. The individual has over 18 years of experience in sales, business development, key account management, and service operations with multinational companies in healthcare. They are seeking a challenging role utilizing their experience in sales, marketing, team management, and strategic planning.
Marc Hollingworth Director Of Sales And Marketing Resume Mmpeterh
Marc Hollingworth is an accomplished sales and marketing executive with over 20 years of experience launching medical devices and pharmaceutical products. He has increased sales by 65% and revenues exceeding $400 million. Hollingworth holds an MBA and has expertise in business planning, new business development, team management, and financial acumen. He has worked for companies in ophthalmology, medical devices, and pharmaceuticals.
This document provides a summary and curriculum vitae for Steven R. Vallespir, including his professional experience, education, awards, areas of therapeutic expertise, licensing evaluations conducted, and publications. Key points include over 30 years of experience in pharmaceutical marketing, business development, licensing, and new product development. He has held roles such as CEO, VP Marketing, Director of Business Development, and Associate Director. Results include developing a $1 billion product and presenting before the Venture Association of New Jersey where he received third place.
The document provides advice and strategies for transformational growth in the pharmaceutical industry. It discusses how the traditional models of blockbuster drugs and generic copies are being disrupted, requiring companies to reinvent themselves. The key strategies suggested include focusing on niche specialty products, branded generics, consumer healthcare, emerging markets, and biotech/diagnostics. The document emphasizes the need to start transforming now through small steps and immediate opportunities. It introduces the advisory team at The Pharma Partners who have deep experience across various areas to help guide strategic transformations.
Andrew Howden is a senior executive with extensive experience in the pharmaceutical industry across Asia, Australia, Europe, and Japan. He has held leadership roles such as CEO, Chairman, and Director for both public and private companies. Howden has a proven track record of developing growth strategies, managing acquisitions, and improving profitability. He currently holds executive positions with First Pharma P/L and The True Origins Company P/L in Australia.
Stephanie Manni has 15 years of experience in sales, marketing, operations and strategic planning across multiple industries including pharmaceuticals, medical devices, healthcare and relocation services. She has a track record of exceeding sales targets and growing business in new territories. Her experience includes positions at Pfizer, Cranial Technologies, Santa Fe Relocation Services and others. She holds a Masters in Public Administration and a BS in Business Management.
Stephen Swanston is an experienced executive sales representative with over 20 years of experience in sales, business development, and pharmaceutical market research. He has expertise in logistics sales, pharmaceutical sales, strategic alliances, and consultative sales management. His resume outlines his professional experience holding sales roles at several companies in the healthcare and logistics industries, including Cove Logistics, Dove Logistics, ComSec International, Baseline Tech Solutions, and GlaxoSmithKline, where he achieved revenue growth and new business.
Robert Paltridge has over 31 years of experience in medical device general management and sales management. He has a proven track record of success with start-ups, turnarounds, and Fortune 500 companies through strategic planning, leadership, and recruiting. Most recently, he served as President of the Extremity Reconstruction Division at Integra LifeSciences Corporation, growing sales to $150 million.
Merro Pharmaceutical is a leading manufacturer, wholesaler, and retailer of prescription and non-prescription drugs and nutritional supplements in China. It is located in Dalian, a major industrial and commercial hub in Northeast China. Merro has over 3,100 employees and $142 million in annual sales revenue. It was founded in 1925 and has expanded through acquisitions and new facilities, becoming a large pharmaceutical company with various product lines and international approvals and clients. Merro's vision is to become a worldwide partner for the Chinese and overseas markets, including the US market, through expanding its product portfolio and reinforcing its research, development, and corporate personnel.
USA Franchise Launch Specialists helps international franchise companies launch in the US market. They customize their services to each client's needs, which can include serving as the US branch office to manage all aspects of the US franchise launch or providing support in specific business areas. Their team of experts has extensive experience launching and expanding franchises across many industries in over 50 countries. They reduce costs and risks for clients while maximizing returns on their investment in the US market.
This document contains a summary of Kirby R. Ryan Jr.'s experience and qualifications. It lists his contact information at the top and includes a summary highlighting his experience in corporate leadership, sales, business development, strategic planning, and healthcare. The bulk of the document consists of descriptions of his roles and accomplishments in senior leadership positions in healthcare companies over the past 20 years.
This document contains a summary and contact information for Kirby R. Ryan Jr., followed by details of his professional experience including positions as Vice President of Sales and Business Development for various healthcare companies. He has experience launching new business lines and products, developing strategic plans, managing sales teams, and starting up new companies in the healthcare field.
Hilario De La Pena is seeking a sales opportunity and has over 30 years of experience in medical equipment and pharmaceutical sales. He has consistently achieved over 15% annual sales growth and received numerous awards and recognition for exceeding sales quotas and goals. His experience includes selling patient handling equipment, medical gas equipment, hospital products and furniture, and pharmaceuticals to hospitals, medical centers, and physicians.
Rudi Jansen is a business executive with over 25 years of experience in the pharmaceutical industry. He has held CEO positions in Europe and has extensive experience turning around businesses. He is seeking new executive positions and enjoys developing businesses, fundraising, and working with teams.
Steven M. Green is an award-winning sales executive with success introducing medical products across Europe and the US. He established a $40 million market for Angiox in Europe in only 2 years and is ranked in the top 10 sales executives in the US. Green has expertise growing sales through international strategies, leading teams, and engaging with decision makers. Recent successes include growing Recothrom sales by over 8% to $2.2 million and increasing Cleviprex sales 250% to $5.6 million with a team of four.
Dwayne Poteet has over 35 years of experience in sales and business development, primarily in the medical device industry. He has a proven track record of exceeding sales goals and establishing distribution networks in over 70 countries. Most recently, as Director of Global Government Solutions at Welch Allyn, he secured over $1.1 million in contracts for medical monitors with the Department of Homeland Security and equipment for immigration detention centers. Poteet has held leadership roles at several medical device companies, growing international sales from six figures to $22 million.
The document discusses strategic alliances and joint ventures between pharmaceutical companies. It provides details of four examples of partnerships: Merck partnered with Alnylam in a non-equity strategic alliance to collaborate on RNAi drug development. GSK partnered with Dong-A through an equity strategic alliance to co-promote products in South Korea. Hisun and Pfizer formed a joint venture to collaborate on local production and distribution in China. Intrexon partnered with Sun Pharmaceuticals through a joint venture to develop new methods for treating ocular diseases using synthetic biology.
Chris Conner has over 18 years of experience in pharmaceutical sales, specializing in oncology and infectious diseases. He has held several executive sales specialist roles promoting products for conditions like chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom's macroglobulinemia, ulcerative colitis, and hepatitis C. Conner has a track record of success launching new products and growing market share. He has received numerous awards for sales performance and leadership. Currently, Conner works as a senior executive oncology specialist for Janssen Biotech, promoting their treatment for hematologic malignancies.
CJR Advisors provides strategic marketing and commercial assessment consulting services. Charlie Raffin is the president and has over 30 years of experience in various roles within Johnson & Johnson, including vice president positions assessing new products and developing global marketing strategies. He has extensive leadership experience in the pharmaceutical and diagnostic industries.
CJR Advisors provides strategic marketing and commercial assessment consulting services. Charlie Raffin is the president and has over 30 years of experience in various roles within Johnson & Johnson, including vice president positions assessing new products and developing global marketing strategies. He has extensive leadership experience in the pharmaceutical and diagnostic industries.
This document contains a summary of an individual's contact information, objective, professional experience, and key strengths. The individual has over 18 years of experience in sales, business development, key account management, and service operations with multinational companies in healthcare. They are seeking a challenging role utilizing their experience in sales, marketing, team management, and strategic planning.
Marc Hollingworth Director Of Sales And Marketing Resume Mmpeterh
Marc Hollingworth is an accomplished sales and marketing executive with over 20 years of experience launching medical devices and pharmaceutical products. He has increased sales by 65% and revenues exceeding $400 million. Hollingworth holds an MBA and has expertise in business planning, new business development, team management, and financial acumen. He has worked for companies in ophthalmology, medical devices, and pharmaceuticals.
This document provides a summary and curriculum vitae for Steven R. Vallespir, including his professional experience, education, awards, areas of therapeutic expertise, licensing evaluations conducted, and publications. Key points include over 30 years of experience in pharmaceutical marketing, business development, licensing, and new product development. He has held roles such as CEO, VP Marketing, Director of Business Development, and Associate Director. Results include developing a $1 billion product and presenting before the Venture Association of New Jersey where he received third place.
The document provides advice and strategies for transformational growth in the pharmaceutical industry. It discusses how the traditional models of blockbuster drugs and generic copies are being disrupted, requiring companies to reinvent themselves. The key strategies suggested include focusing on niche specialty products, branded generics, consumer healthcare, emerging markets, and biotech/diagnostics. The document emphasizes the need to start transforming now through small steps and immediate opportunities. It introduces the advisory team at The Pharma Partners who have deep experience across various areas to help guide strategic transformations.
Andrew Howden is a senior executive with extensive experience in the pharmaceutical industry across Asia, Australia, Europe, and Japan. He has held leadership roles such as CEO, Chairman, and Director for both public and private companies. Howden has a proven track record of developing growth strategies, managing acquisitions, and improving profitability. He currently holds executive positions with First Pharma P/L and The True Origins Company P/L in Australia.
Stephanie Manni has 15 years of experience in sales, marketing, operations and strategic planning across multiple industries including pharmaceuticals, medical devices, healthcare and relocation services. She has a track record of exceeding sales targets and growing business in new territories. Her experience includes positions at Pfizer, Cranial Technologies, Santa Fe Relocation Services and others. She holds a Masters in Public Administration and a BS in Business Management.
Stephen Swanston is an experienced executive sales representative with over 20 years of experience in sales, business development, and pharmaceutical market research. He has expertise in logistics sales, pharmaceutical sales, strategic alliances, and consultative sales management. His resume outlines his professional experience holding sales roles at several companies in the healthcare and logistics industries, including Cove Logistics, Dove Logistics, ComSec International, Baseline Tech Solutions, and GlaxoSmithKline, where he achieved revenue growth and new business.
Robert Paltridge has over 31 years of experience in medical device general management and sales management. He has a proven track record of success with start-ups, turnarounds, and Fortune 500 companies through strategic planning, leadership, and recruiting. Most recently, he served as President of the Extremity Reconstruction Division at Integra LifeSciences Corporation, growing sales to $150 million.
Merro Pharmaceutical is a leading manufacturer, wholesaler, and retailer of prescription and non-prescription drugs and nutritional supplements in China. It is located in Dalian, a major industrial and commercial hub in Northeast China. Merro has over 3,100 employees and $142 million in annual sales revenue. It was founded in 1925 and has expanded through acquisitions and new facilities, becoming a large pharmaceutical company with various product lines and international approvals and clients. Merro's vision is to become a worldwide partner for the Chinese and overseas markets, including the US market, through expanding its product portfolio and reinforcing its research, development, and corporate personnel.
USA Franchise Launch Specialists helps international franchise companies launch in the US market. They customize their services to each client's needs, which can include serving as the US branch office to manage all aspects of the US franchise launch or providing support in specific business areas. Their team of experts has extensive experience launching and expanding franchises across many industries in over 50 countries. They reduce costs and risks for clients while maximizing returns on their investment in the US market.
This document contains a summary of Kirby R. Ryan Jr.'s experience and qualifications. It lists his contact information at the top and includes a summary highlighting his experience in corporate leadership, sales, business development, strategic planning, and healthcare. The bulk of the document consists of descriptions of his roles and accomplishments in senior leadership positions in healthcare companies over the past 20 years.
This document contains a summary and contact information for Kirby R. Ryan Jr., followed by details of his professional experience including positions as Vice President of Sales and Business Development for various healthcare companies. He has experience launching new business lines and products, developing strategic plans, managing sales teams, and starting up new companies in the healthcare field.
Hilario De La Pena is seeking a sales opportunity and has over 30 years of experience in medical equipment and pharmaceutical sales. He has consistently achieved over 15% annual sales growth and received numerous awards and recognition for exceeding sales quotas and goals. His experience includes selling patient handling equipment, medical gas equipment, hospital products and furniture, and pharmaceuticals to hospitals, medical centers, and physicians.
1. J. Scott Laprise
DOB-04/11/62 Married Canadian Citizen
86 158 1048 7033
EMPLOYMENT
C L S A B E I J I N G (Beijing, China) October 2009 - January 2015
Headquartered in Hong Kong, CLSA has over 1,500 employees located in 21 cities across Asia-Pacific, as
well as Europe and the USA. CLSA’s parent company is CITIC Securities, one of Asia’s leading
investment banks. CLSA is Asia’s leading and longest-running independent brokerage and investment
group. The company provides equity broking and execution services, corporate finance and asset
management services to global corporate and institutional clients.
AUTO, STEEL AND HEALTHCARE ANALYST
As a stock analyst, responsibilities to write at least 1 report per week on stocks under coverage and
give clients a 1-2 year view on how the stocks will move up or down. Focus is mainly on the
quantitative analysis of a stock but use also the qualitative analysis to form your arguments for or
against buying or selling a stock.
Focus on 3 major centers for helping clients: New York, London and Hong Kong with personally over
1000 clients reading the reports.
Meeting clients when they come to visit in Beijing or roadshows visiting clients to discuss the autos,
steel and healthcare sectors.
Need to be reactive to the changes in the stock market as needed such as writing reports overnight
to cover the impact of decline in the Russian Rouble on the stocks. At the same time, keep a longer
term view on how the fundamentals will move for my sectors and stocks under coverage.
Wall Street Journal Analyst of the year for all of China 2012.
#1 at CLSA in terms of best calls for 3 years 2010-2012.
Differentiation being located in China whereas my colleagues are almost all in Hong Kong. Not only
able to analyze company financials but look at companies more from a complete view using
management experience.
Primary stock coverage is Angang, Magang, Bengang, Shanghai Auto, Great Wall, Brilliance,
Dongfeng Auto, Guangzhou Auto, Zhengtong, Shougang and Shandong Weigao. Very familiar with
Minth, Mindray, China Grand Auto, Autohome, BitAuto and others.
Worked on many/potential IPO’s such as Beijing Auto.
C L S A S H A N G H A I (Shanghai, China) October 2006 - 2009
AUTO, STEEL AND HEALTHCARE ANALYST
Primary coverage is Angang, Magang, Bengang, Shanghai Auto, Great Wall, Dongfeng Auto, Denway,
Shougang and Shandong Weigao.
L T H C H I N A C O N S U L T I N G January 2001 – October 2006
Founded LTH China Consulting Company. Business focus to advise and consult foreign companies.
GENERAL MANAGER
Exclusive Representative of US Company Fisher Scientifics’ diagnostic products. Fisher companies
responsible for Microgenics drug monitoring, Pacific Homeostasis in coagulation, CTI for internal
quality control, and Seradyn for reagents.
Set up China distribution network for Pacific Homeostasis in 2005. Sales for 6 months in 2004 were
US$250,000, in 2005 more than US$850,000 despite the brand losing world-wide market share.
Helped different companies in different industries in China such as:
o Beijing 911 telephone systemfor the Olympics.
o Consumer goods- Juice company - growing 23 varieties of raspberries with purpose to
introduce a new fruit flavour to China.
A V L M E D I C A L I N S T R U M E N T S (Beijing, China) January 2000 – April 2000
AVL purchased by Roche April 2000. AVL is a blood gas and electrolyte testing equipment for the
laboratory and physician office market. Sales over US$100 million.
GENERAL MANAGER CHINA
Held #1 market position for blood gas and Electrolyte testing in China.
30 employees with 7 offices in China plus various distributor relationships. As well responsible for
Hong Kong and Macau markets.
Set up “Wholly Owned Foreign Enterprise Company” to allow us to do direct selling.
Was hired to clean up the money loosing operation and eventually take over the Asia Region.
D A D E B E H R I N G A S I A (Singapore) January 1995 - November 1998
Dade Behring, 3rd
in sales in its segment, a large multinational manufacturer of medical products.
Behring in late 1997 was merged with Dade, while Hoechst AG(now Sanofi Aventis) (Hoechst AG
Frankfurt, Germany, 63rd
largest company in the world with sales in 1997 of DM 52.1 Billion with
2. 118,000 employees) retained 40% of the stock. Dade was made up of Bain Capital and Goldman Sachs.
They came in 1998 to reorganize the company.
MANAGING DIRECTOR ASIA
Began with 20 distributors and in 1 year changed into 6 direct 100% wholly owned direct operations.
Previously managed from Germany, I set up a Regional Office in Singapore. Started with sales
DM6,000,000 and turned it into a DM25,000,000 operation.
Direct operations for Thailand, Malaysia, Singapore, Philippines, Indonesia, Hong Kong, and
distributors in China, Taiwan, Brunei and Vietnam.
Net profit of 36% with 13 direct reports and a staff of over 100 employees region wide.
Full profit and loss responsibility.
Negotiated and designed joint venture plan for our Taiwanese distributor.
1997 President’s Award for exceeding plan by 127%. Malaysia 2nd
and Thailand 4th
of 40 countries.
B E H R I N G D I A G N O S T I C S (San Jose, Ca.) 1994 - 1995
1994 Hoechst, parent company of Behring, purchased Syva.
MARKETING MANAGER, ASIA-PACIFIC DIVISION
Managed subsidiaries in Japan, Australia, and New Zealand and distributors in Thailand, Malaysia,
Singapore, Philippines, Indonesia, Hong Kong, China, Taiwan, Brunei and Vietnam.
4 direct reports in Japan, New Zealand and Australia total staff of 17. Japan represented the largest
% of sales as well as staff. In 1994-95, achieved 104% of goal.
Japan-worked on lobbying the government to changes in their laws concerning drug testing.
S Y V A C O M P A N Y (San Jose, Ca.) 1993 - 1994
A wholly owned subsidiary of Syntex Corporation (headquartered in California) with 9,000 employees
USD 2 Billion in sales in healthcare. Syntex was sold to Roche and our division was sold to Hoechst .
COMMERCIAL MARKETING MANAGER, ASIA-PACIFIC DIVISION
Sales and profit responsibility for distributors in Singapore, Hong Kong, China, Taiwan, Thailand,
Philippines, Guam. 1993 110% of goal, 3rd of 20 units in % growth (only 3 units were above plan).
1994 added Mexico General Manager. Largest % growth for any operation (118%) turning around a
non-profitable organization. Grew sales from USD 1.2M to 2.2M and net profit of 51%.
Developed new distribution network in China and Hong Kong.
S Y V A C O M P A N Y (San Jose, Ca.) 1991-1993
MARKETING MANAGER, INTERNATIONAL DIVISION
Product line management at Head Office for Drugs of Abuse Testing market for 53 countries.
Development of European market and new product development. 50% of International sales.
S Y V A C A N A D A (Ottawa, Ontario) 1989-1991
MARKETING MANAGER
Recruited from Abbott to help rebuild an organization with profits dropping and sales flat.
Responsible for marketing and operations.
Turned the organization into a high-performing organization and was promoted to the Head Office.
A B B O T T L A B O R A T O R I E S (Montreal Quebec) 1985-1989
A USD 12 billion healthcare company with 56,000 employees worldwide and #1 diagnostics industry
leader. Ranked 115th
largest USA based corporation and ranked 21st
in profits as a percent of sales.
SALES AND PRODUCT MANAGEMENT
Clinical Chemistry Specialist selling 100K+ capital equipment.
Clinical Chemistry Specialist of the year 1989. Presidents Club 1998 member, top 10% of sales.
EDUCATION
1999 University of Foreign Language Studies, Shanghai, China - Mandarin Language Studies, Level 1 & 2.
1985 McGill University, Montreal, Quebec Continuing Education.
MBA Courses: Management Information Systems and Financial Accounting.
1984 University of Grenoble, Grenoble, France - Bachelor of Arts Courses.
1984 University of Western Ontario - Bachelor of Administrative and Commercial Studies.
Majors: Finance, Marketing, and Computer Science. Fluent in English, French, and spoken Mandarin.
OTHER
Built a school in Sichuan with a work colleague for poor children.
Assistant Coach Ice Hockey, China sports school to be trained for the National team, Harbin, China.
Play ice hockey in Asia-wide tournaments (Thailand, Malaysia, Philippines, Mongolia, Singapore).